New "Smart Chemo" like a Heat-Seeking Missile Against Cancer
There's a little-known biotech almost nobody knows about...
Its stock trades at just $4 per share ...but the company recently won an FDA approval for its "Smart Chemo" drug for lymphoma.
Our last "Smart Chemo" pick won FDA approval and soared from $5.30 to $28.89, a gain of 463% in 18 months.
Get the name of the stock here... before it's too late.
All the best,
Simmy Adelman, Publisher
Behind the Markets
